Stocks
ETFs
Crypto
close
rumor
rumor
Search
⌘K
Screeners
Heatmaps
Trends
News
You're viewing limited data.
Log in
Sign up
close
close
Sign up
Sign up
Log in
Pricing
1 asset
Market news
Type
All
All
Stocks
ETFs
Crypto
Sort
Newest
Newest
Oldest
Published
All
Publisher
All
Assets
RYTM
Asset
Type
All
Stocks
ETFs
Crypto
All
Stocks
ETFs
Crypto
Type
All
All
Sort
Newest
Oldest
Newest
Oldest
Sort
Newest
Newest
Published
All
All
Publisher
All
All
Filter by asset
Stocks
ETFs
Crypto
close
Rhythm Pharmaceuticals president & CEO Meeker sells $5.13m stock
Sep 15
Investing.com
RYTM
Obesity Market to Witness Strong Growth and Significant Market Expansion by 2036 – DelveInsight | Rhythm Pharma, Boehringer Ingelheim, D&D Pharmatech, ProQR Therapeutics, Nano Precision Medical
Sep 10
Barchart.com
PRQR
RYTM
Rhythm Pharmaceuticals at Wells Fargo conference: ho launch gains traction
Sep 9
Investing.com
RYTM
WFC
Rhythm Pharmaceuticals CTO Joseph Shulman sells $608,210 of stock
Aug 17
Investing.com
RYTM
Rhythm Pharmaceuticals CSO Alastair Garfield sells $912,703 in stock
Aug 17
Investing.com
RYTM
Rhythm Pharmaceuticals EVP Mazabraud sells $6.6m in stock
Aug 14
Investing.com
RYTM
Rhythm Pharmaceuticals EVP, Jennifer Lee, sells $8.9m in stock
Aug 14
Investing.com
RYTM
Rhythm Pharmaceuticals at Canaccord Genuity: launch gains widen
Aug 12
Investing.com
RYTM
Citizens raises Rhythm Pharmaceuticals price target on strong launch
Aug 5
Investing.com
RYTM
Rhythm Pharmaceuticals reports RM-718 trial results in obesity
Aug 5
Investing.com
RYTM
Rhythm Pharma earnings beat by $0.08, revenue topped estimates
Aug 4
Investing.com
RYTM
JPMorgan initiates Rhythm Pharmaceuticals stock at Overweight
Jul 27
Investing.com
RYTM
Tracking Baker Brothers Portfolio: Q1 2026 Update
Jul 21
Seeking Alpha
MDGL
RYTM
Citizens reiterates Rhythm Pharmaceuticals stock rating on strong Imcivree launch data
Jul 14
Investing.com
RYTM
This is the newest page. Registered accounts read further back.
Register to keep reading